Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.41
-
NAV
₹9.64
-
Fund Started
10 Nov 2025
-
Fund Size
₹279.60 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 30 days.
-
1 Year
-
-
3 Year
-
-
5 Year
-
-
Equity
95.37%
-
Cash
4.60%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 8.56% |
Apollo Hospitals Enterprise Ltd. | 8.22% |
Divi's Laboratories Ltd. | 7.36% |
Max Healthcare Institute Ltd. | 6.93% |
Dr. Reddy's Laboratories Ltd. | 6.75% |
Cipla Ltd. | 6.01% |
JB Chemicals & Pharmaceuticals Ltd. | 5.35% |
Mankind Pharma Ltd. | 3.95% |
Lupin Ltd. | 3.46% |
Ajanta Pharma Ltd. | 3.23% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
-
Launch Date
10 Nov 2025
-
